Gold scales over 1-month peak on mounting economic worries

Author of the article: Gold prices hit a more than one-month high on Monday, carrying momentum from a sharp gain in the previous session on concerns over a potential blow to the U.S. economy from an aggressive Federal Reserve approach to combating inflation. FUNDAMENTALS * Spot gold firmed 0.1% to $1,872.53 per ounce, as of…
Gold scales over 1-month peak on mounting economic worries

Author of the article:

Gold prices hit a more than one-month

high on Monday, carrying momentum from a sharp gain in the

previous session on concerns over a potential blow to the U.S.

economy from an aggressive Federal Reserve approach to combating

inflation.

FUNDAMENTALS

* Spot gold firmed 0.1% to $1,872.53 per ounce, as of

0059 GMT, while U.S. gold futures edged 0.1% higher to

$1,876.60.

* Gold is seen as a safe-haven in times of economic crises,

and hit its highest since May 9 earlier in the session at

$1,877.05 per ounce.

* However, benchmark U.S. 10-year Treasury yields

also rose to their highest since May 9, capping

demand for zero-yield gold.

* Also limiting gains in greenback-priced gold, the dollar

climbed to its highest in nearly four weeks.

* Gold prices saw volatile trading on Friday, as focus

turned to economic risks after elevated U.S. inflation readings

bolstered bets for aggressive interest rate hikes.

* Global equity markets slumped and the dollar strengthened

on Friday after a bigger-than-expected U.S. inflation spike in

May raised concerns the Federal Reserve may tighten policy for

too long and cause a sharp slowdown.

* U.S. consumer prices accelerated in May, suggesting that

the country’s central bank could continue with its 50 basis

points interest rate hikes through September to combat

inflation.

* It’s a central-bank heavy week ahead, with the Fed

expected to deliver its second straight half-point rate hike to

bring inflation under control.

* Bullion is often seen as an inflation hedge, but the

opportunity cost of holding it is higher when the Fed raises

short-term interest rates, as gold yields no interest.

* Spot silver dipped 0.9% to $21.68 per ounce,

platinum fell 0.6% to $967.67, and palladium

dropped 1.3% to $1,909.49.

DATA/EVENTS (GMT, April)

0600 UK GDP Est 3M/3M

0600 UK GDP Estimate MM, YY

0600 UK Manufacturing Output MM

(Reporting by Bharat Govind Gautam in Bengaluru; Editing by

Rashmi Aich)

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Thousands of flights canceled globally as Omicron mars Christmas weekend
Read More

Thousands of flights canceled globally as Omicron mars Christmas weekend

Author of the article: NEW YORK — Commercial airlines around the world canceled more than 4,500 flights over the Christmas weekend, as a mounting wave of COVID-19 infections driven by the Omicron variant created greater uncertainty and misery for holiday travelers. Airline carriers globally scrapped at least 2,401 flights on Friday, which fell on Christmas…
U.S. airlines grapple with Omicron-related disruptions on last day of the year
Read More

U.S. airlines grapple with Omicron-related disruptions on last day of the year

Author of the article: Thousands of flights within the United States and internationally were delayed or canceled on Friday, adding to the travel disruptions during the holiday week due to adverse weather and rising cases of the Omicron coronavirus variant https://www.reuters.com/world/us/experts-warn-omicron-blizzard-disrupt-us-next-month-2021-12-30. Over 3,090 flights were canceled globally as of early Friday evening, including nearly 1,550…
U.S. FDA panel votes against Amylyx’s ALS drug over trial data concerns
Read More

U.S. FDA panel votes against Amylyx’s ALS drug over trial data concerns

Author of the article: A panel of outside advisers to the U.S. Food and Drug Administration on Wednesday voted against approving Amylyx Pharmaceuticals Inc’s drug for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease. The committee voted 6 to 4 against the oral drug, AMX0035, saying the company’s clinical study data failed to establish that it…